PER 2.50% 8.2¢ percheron therapeutics limited

anticipated announcements - q1 2012, page-10

  1. SRF
    1,046 Posts.
    For those who are interested, here is an interesting article on iPSC stem cells used for research and drug development of genetic diseases, which I think could be the new and ideal way of trialing antisense compounds.

    http://www.sciencedirect.com/science/article/pii/S0092867408010015



    The MS stem cells on a dish I mentioned earlier:
    http://www.smh.com.au/technology/sci-tech/scientists-unveil-first-ms-stem-cell-model-20111221-1p5l4.html.


    This will save cost and time with almost unliited trials without human safety issues.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.